𝔖 Bobbio Scriptorium
✦   LIBER   ✦

Panitumumab–FOLFOX4 Treatment and RAS Mutations in Colorectal Cancer

✍ Scribed by Douillard, Jean-Yves; Oliner, Kelly S.; Siena, Salvatore; Tabernero, Josep; Burkes, Ronald; Barugel, Mario; Humblet, Yves; Bodoky, Gyorgy; Cunningham, David; Jassem, Jacek; Rivera, Fernando; Kocákova, Ilona; Ruff, Paul; Błasińska-Morawiec, Maria; Šmakal, Martin; Canon, Jean Luc; Rother, Mark; Williams, Richard; Rong, Alan; Wiezorek, Jeffrey; Sidhu, Roger; Patterson, Scott D.

Book ID
125488433
Publisher
Massachusetts Medical Society
Year
2013
Tongue
English
Weight
876 KB
Volume
369
Category
Article
ISSN
0096-6762

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

Association of K-ras Mutational Status a
Association of K-ras Mutational Status and Clinical Outcomes in Patients with Metastatic Colorectal Cancer Receiving Panitumumab Alone
✍ Daniel J. Freeman; Todd Juan; Maureen Reiner; J. Randolph Hecht; Neal J. Meropol 📂 Article 📅 2008 🏛 CIG Media Group, LP. 🌐 English ⚖ 502 KB

Background: Identifying predictive biomarkers is important to optimally treat patients. This analysis evaluated the association of K-ras, BRAF, and PIK3CA gene mutations with tumor resistance to panitumumab alone. Patients and Methods: From 3 phase II panitumumab metastatic colorectal cancer (mCRC)